Related Experiment Videos
Internal mammary lymphoscintigraphy in breast carcinoma: a study of 1072 patients
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Magnetic resonance imaging, computed tomography, and radionuclide scintigraphy in detection of liver metastases.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·1988
Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1986
Comparison as a lymphoscintigraphic agent between 99Tcm dextran and 99Tcm antimony sulphide colloid.
The British journal of radiology·1985
The relevance of internal mammary lymphoscintigraphy in the management of breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1984
STOP Lower Cranial Neuropathy: High-Dose Corticosteroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors: Interim Analysis of a Phase I Dose-Finding Trial.
International journal of radiation oncology, biology, physics·2026
A Modular Multi-Agent Reinforcement Learning Framework Guided by LLMs: Improving Quality and Efficiency of Treatment Planning in Lung Radiotherapy.
International journal of radiation oncology, biology, physics·2026
A combined dose and microdosimetric modeling framework incorporating volume effects correlates with tissue sparing in proton minibeam radiotherapy.
International journal of radiation oncology, biology, physics·2026
Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer.
International journal of radiation oncology, biology, physics·2026
Clinical and Treatment Factors associated with Lymphopenia after Palliative Radiation Therapy in Cancer Patients.
International journal of radiation oncology, biology, physics·2026
Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy.
International journal of radiation oncology, biology, physics·2026